U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Inspection Basics
  4. FDA’s Risk-Based Approach to Inspections
  1. Inspection Basics

FDA’s Risk-Based Approach to Inspections

The FDA uses a risk-based evaluation to select foreign and domestic medical product manufacturing facilities for inspection The agency prioritizes medical product surveillance inspections deemed high-risk based on a variety of specific criteria, such as:  

  • facility type, such as manufacturer, control laboratory, etc.
  • the facility’s compliance history, including whether it has been inspected in the last four years
  • hazard signals, including the record of signals, history and nature of product recalls linked to the facility, etc.
  • inherent risks of the product manufactured at a facility, such as dosage form, route of administration, products intended to be sterile, concentration of active pharmaceutical ingredient in dosage form, emergency use, etc.
  • whether the facility has been inspected by a foreign regulatory partner

For example, a sterile drug manufacturing site that has not been previously inspected and is making narrow therapeutic index drugs would likely be deemed a higher risk than a site that had a well-known inspectional and compliance history that is making over-the-counter solid oral dosage form drugs. 

For bioresearch monitoring (clinical and non-clinical research) inspections, the agency considers several risk-based factors, including:

  • compliance history
  • complaints associated with the site
  • number of applications the site is associated with
  • enrollment numbers
  • number of protocol exceptions/deviations
  • data anomalies

Human and animal food inspections are driven by the Food Safety Modernization Act inspection frequency mandate that requires domestic high-risk facilities to be inspected every three years and non-high-risk facilities are inspected every five years. 

Back to Top